27
Oversold
Moving averages
SMA 200$52.68-25.78%
Company profile
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
SectorHealthcare
IndustryBiotechnology
Market cap$4.44B
P/E ratioNone
EPS$-4.73
Beta1.897
Dividend yield0.00%
52-week high$63.45
52-week low$42.38
ETFs holding CRSP
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
IOVA
Iovance Biotherapeutics Inc
RSI 31
IBRX
ImmunityBio Inc
RSI 40
TARS
Tarsus Pharmaceuticals Inc
RSI 54
VKTX
Viking Therapeutics Inc
RSI 44
ATAI
ATAI Life Sciences N.V.
RSI 62
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
RSI alerts for CRSP
An email when CRSP closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 12:30 AM EST